{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:10:28Z","timestamp":1778670628998,"version":"3.51.4"},"reference-count":15,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/01446"],"award-info":[{"award-number":["PI20\/01446"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008057","name":"Health Research Institute La Fe","doi-asserted-by":"publisher","award":["Beca Post Residencia \/ 2023-875-1"],"award-info":[{"award-number":["Beca Post Residencia \/ 2023-875-1"]}],"id":[{"id":"10.13039\/100008057","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundaci\u00f3n ONCE","award":["Oportunidad al talento"],"award-info":[{"award-number":["Oportunidad al talento"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_almed-2025-0098_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We aimed to develop a simple, cost-effective algorithm to predict the presence of oligoclonal IgM bands (OCMB) in patients with multiple sclerosis (MS), using surrogate markers such as the IgM Index (IgMi) and the Free Kappa Light Chains Index (FKLCi), with the aim of reducing the need for OCMB testing while maintaining high diagnostic accuracy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_almed-2025-0098_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective study was conducted using paired serum and cerebrospinal fluid samples from patients diagnosed with MS at disease onset at Hospital Universitari i Polit\u00e8cnic La Fe. Receiver operating characteristic (ROC) curve analyses were performed for IgMi and FKLCi to evaluate their ability to predict OCMB positivity. Several combinations of cutoff values prioritizing high specificity and positive predictive value (PPV) were tested, and the best-performing threshold combination was selected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_almed-2025-0098_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 97 patients were included. The optimal model defined OCMB positivity as having either IgMi\u22650.2 or FKLCi\u2265250. Applying this algorithm reduced the need for OCMB testing by 33\u202f%, while achieving a specificity of 90\u202f% and a PPV of 85\u202f%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_almed-2025-0098_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>IgMi and FKLCi may serve as reliable predictors of OCMB positivity in MS, potentially reducing unnecessary testing and laboratory workload.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/almed-2025-0098","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T20:56:29Z","timestamp":1764968189000},"page":"148-152","source":"Crossref","is-referenced-by-count":0,"title":["An algorithm to predict intrathecal IgM synthesis in multiple sclerosis patients: optimizing the use of oligoclonal band testing"],"prefix":"10.1515","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4622-2173","authenticated-orcid":false,"given":"Jordi","family":"Tortosa-Carreres","sequence":"first","affiliation":[{"name":"Laboratory Department , 16273 La Fe University and Polytechnic Hospital , Valencia , Spain"},{"name":"Neuroimmunology Research Group, Health Research Institute La Fe , Valencia , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4934-3891","authenticated-orcid":false,"given":"Laura","family":"Cubas-N\u00fa\u00f1ez","sequence":"additional","affiliation":[{"name":"Neuroimmunology Research Group, Health Research Institute La Fe , Valencia , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4578-8406","authenticated-orcid":false,"given":"J\u00e9ssica","family":"Castillo-Villalba","sequence":"additional","affiliation":[{"name":"Neuroimmunology Research Group, Health Research Institute La Fe , Valencia , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9824-5076","authenticated-orcid":false,"given":"Lorena","family":"For\u00e9s-Toribio","sequence":"additional","affiliation":[{"name":"Neuroimmunology Research Group, Health Research Institute La Fe , Valencia , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3329-766X","authenticated-orcid":false,"given":"M\u00f3nica","family":"Piqueras","sequence":"additional","affiliation":[{"name":"Laboratory Department , 16273 La Fe University and Polytechnic Hospital , Valencia , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6262-7499","authenticated-orcid":false,"given":"Raquel","family":"Gasque-Rubio","sequence":"additional","affiliation":[{"name":"Neuroimmunology Research Group, Health Research Institute La Fe , Valencia , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0021-3041","authenticated-orcid":false,"given":"Sara","family":"Carratal\u00e0-Bosc\u00e0","sequence":"additional","affiliation":[{"name":"Neuroimmunology Research Group, Health Research Institute La Fe , Valencia , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4681-2456","authenticated-orcid":false,"given":"Carlos","family":"Quintanilla-Bord\u00e1s","sequence":"additional","affiliation":[{"name":"Neurology Department , General University Hospital of Castell\u00f3n , Castell\u00f3 , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Gorriz-Romero","sequence":"additional","affiliation":[{"name":"Neuroimmunology Unit , La Fe University and Polytechnic Hospital , Valencia , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3806-925X","authenticated-orcid":false,"given":"Bonaventura","family":"Casanova","sequence":"additional","affiliation":[{"name":"Neurology Department , General University Hospital of Castell\u00f3n , Castell\u00f3 , Spain"},{"name":"Neuroimmunology Unit , La Fe University and Polytechnic Hospital , Valencia , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bego\u00f1a","family":"Laiz-Marro","sequence":"additional","affiliation":[{"name":"Laboratory Department , 16273 La Fe University and Polytechnic Hospital , Valencia , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3767-3738","authenticated-orcid":false,"given":"Francisco Carlos","family":"P\u00e9rez-Miralles","sequence":"additional","affiliation":[{"name":"Neurology Department , General University Hospital of Castell\u00f3n , Castell\u00f3 , Spain"},{"name":"Neuroimmunology Unit , La Fe University and Polytechnic Hospital , Valencia , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"2026051310150655808_j_almed-2025-0098_ref_001","doi-asserted-by":"crossref","unstructured":"Capuano, R, Zubizarreta, I, Alba-Arbalat, S, Sepulveda, M, Sola-Valls, N, Pulido-Valdeolivas, I, et al.. Oligoclonal IgM bands in the cerebrospinal fluid of patients with relapsing MS to inform long-term MS disability. Mult Scler 2021;27:1706\u201316. https:\/\/doi.org\/10.1177\/1352458520981910.","DOI":"10.1177\/1352458520981910"},{"key":"2026051310150655808_j_almed-2025-0098_ref_002","doi-asserted-by":"crossref","unstructured":"Coll-Martinez, C, Quintana, E, Bux\u00f3, M, Salavedra-Pont, J, Gasull-Vicens, L, Quiroga-Varela, A, et al.. Oligoclonal IgM bands are a promising biomarker for long-term cognitive outcomes in multiple sclerosis. Mult Scler Relat Disord 2022;68:104397. https:\/\/doi.org\/10.1016\/j.msard.2022.104397.","DOI":"10.1016\/j.msard.2022.104397"},{"key":"2026051310150655808_j_almed-2025-0098_ref_003","doi-asserted-by":"crossref","unstructured":"Alcal\u00e1 Vicente, C, Lacruz, L, Gasc\u00f3n, F, Carratal\u00e0, S, Quintanilla-Bord\u00e1s, C, Sanz, MT, et al.. Oligoclonal M bands and cervical spinal cord lesions predict early secondary progressive multiple sclerosis. Front Neurol 2022;13:991596. https:\/\/doi.org\/10.3389\/fneur.2022.991596.","DOI":"10.3389\/fneur.2022.991596"},{"key":"2026051310150655808_j_almed-2025-0098_ref_004","doi-asserted-by":"crossref","unstructured":"Masi, F, Al Qudsi, S, Visigalli, D, Zardini, E, Capello, E, Dicembre, LP, et al.. Oligoclonal IgM band patterns in multiple sclerosis: a two-center study. J\u00a0Neuroimmunol 2025;404:578622. https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578622.","DOI":"10.1016\/j.jneuroim.2025.578622"},{"key":"2026051310150655808_j_almed-2025-0098_ref_005","doi-asserted-by":"crossref","unstructured":"Frau, J, Villar, LM, Sardu, C, Secci, MA, Schirru, L, Ferraro, D, et al.. Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor? J\u00a0Neurol 2018;265:424\u201330. https:\/\/doi.org\/10.1007\/s00415-017-8716-4.","DOI":"10.1007\/s00415-017-8716-4"},{"key":"2026051310150655808_j_almed-2025-0098_ref_006","doi-asserted-by":"crossref","unstructured":"Gastaldi, M, Zardini, E, Franciotta, D. An update on the use of cerebrospinal fluid analysis as a diagnostic tool in multiple sclerosis. Expert Rev Mol Diagn 2017;17:31\u201346. https:\/\/doi.org\/10.1080\/14737159.2017.1262260.","DOI":"10.1080\/14737159.2017.1262260"},{"key":"2026051310150655808_j_almed-2025-0098_ref_007","doi-asserted-by":"crossref","unstructured":"Tortosa-Carreres, J, Quiroga-Varela, A, Castillo-Villalba, J, Piqueras-Rodr\u00edguez, M, Rami\u00f3-Torrenta, L, Cubas-N\u00fa\u00f1ez, L, et al.. Improving the efficiency of free kappa light chains as diagnostic biomarker of multiple sclerosis by using a novel algorithm. Mult Scler Relat Disord 2023;79:104997. https:\/\/doi.org\/10.1016\/j.msard.2023.104997.","DOI":"10.1016\/j.msard.2023.104997"},{"key":"2026051310150655808_j_almed-2025-0098_ref_008","doi-asserted-by":"crossref","unstructured":"Villar, LM, Gonz\u00e1lez-Porqu\u00e9, P, Masju\u00e1n, J, Alvarez-Cerme\u00f1o, JC, Bootello, A, Keir, G, et al.. A sensitive and reproducible method for the detection of oligoclonal IgM bands. J\u00a0Immunol Methods 2001;258:151\u20135. https:\/\/doi.org\/10.1016\/s0022-1759(01)00492-6.","DOI":"10.1016\/S0022-1759(01)00492-6"},{"key":"2026051310150655808_j_almed-2025-0098_ref_009","doi-asserted-by":"crossref","unstructured":"Jongen, PJH, Lycklama, a, Nijeholt, G, Lamers, KJB, Doesburg, WH, Barkhof, F, et al.. Cerebrospinal fluid IgM index correlates with cranial MRI lesion load in patients with multiple sclerosis. Eur Neurol 2007;58:90\u20135. https:\/\/doi.org\/10.1159\/000103643.","DOI":"10.1159\/000103643"},{"key":"2026051310150655808_j_almed-2025-0098_ref_010","doi-asserted-by":"crossref","unstructured":"Ozakbas, S, Cinar, BP, \u00d6zcelik, P, Baser, H, Kosehasano\u011fullari, G. Intrathecal IgM index correlates with a severe disease course in multiple sclerosis: clinical and MRI results. Clin Neurol Neurosurg 2017;160:27\u20139. https:\/\/doi.org\/10.1016\/j.clineuro.2017.05.026.","DOI":"10.1016\/j.clineuro.2017.05.026"},{"key":"2026051310150655808_j_almed-2025-0098_ref_011","doi-asserted-by":"crossref","unstructured":"Rosenstein, I, Axelsson, M, Novakova, L, Malmestr\u00f6m, C, Blennow, K, Zetterberg, H, et al.. Intrathecal kappa free light chain synthesis is associated with worse prognosis in relapsing-remitting multiple sclerosis. J\u00a0Neurol 2023;270:4800\u201311. https:\/\/doi.org\/10.1007\/s00415-023-11817-9.","DOI":"10.1007\/s00415-023-11817-9"},{"key":"2026051310150655808_j_almed-2025-0098_ref_012","doi-asserted-by":"crossref","unstructured":"Tortosa-Carreres, J, Cubas-N\u00fa\u00f1ez, L, Quiroga-Varela, A, Castillo-Villalba, J, Rami\u00f3-Torrenta, L, Piqueras, M, et al.. Predictive potential of serum and cerebrospinal fluid biomarkers for disease activity in treated multiple sclerosis patients. Mult Scler Relat Disord 2024;88:105734. https:\/\/doi.org\/10.1016\/j.msard.2024.105734.","DOI":"10.1016\/j.msard.2024.105734"},{"key":"2026051310150655808_j_almed-2025-0098_ref_013","doi-asserted-by":"crossref","unstructured":"Oechtering, J, Lincke, T, Schaedelin, S, D\u00e9card, BF, Maceski, A, Orleth, A, et al.. Intrathecal IgM synthesis is associated with spinal cord manifestation and neuronal injury in early MS. Ann Neurol 2022;91:814\u201320. https:\/\/doi.org\/10.1002\/ana.26348.","DOI":"10.1002\/ana.26348"},{"key":"2026051310150655808_j_almed-2025-0098_ref_014","doi-asserted-by":"crossref","unstructured":"Monreal, E, Sainz de la Maza, S, Costa-Frossard, L, Walo-Delgado, P, Zamora, J, Fern\u00e1ndez-Velasco, JI, et al.. Predicting aggressive multiple sclerosis with intrathecal IgM synthesis among patients with a clinically isolated syndrome. Neurol Neuroim Neuroinfl 2021;8:e1047. https:\/\/doi.org\/10.1212\/nxi.0000000000001047.","DOI":"10.1212\/NXI.0000000000001047"},{"key":"2026051310150655808_j_almed-2025-0098_ref_015","doi-asserted-by":"crossref","unstructured":"Casanova, B, Castillo, J, Quintanilla-Bord\u00e1s, C, Sanz, MT, Fern\u00e1ndez-Velasco, JI, Alcal\u00e1, C, et al.. Oligoclonal M bands unveil occult inflammation in multiple sclerosis. Mult Scler Relat Disord 2022;68:104118. https:\/\/doi.org\/10.1016\/j.msard.2022.104118.","DOI":"10.1016\/j.msard.2022.104118"}],"container-title":["Advances in Laboratory Medicine \/ Avances en Medicina de Laboratorio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/almed-2025-0098\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/almed-2025-0098\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T10:21:11Z","timestamp":1778667671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/almed-2025-0098\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":15,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4,28]]},"published-print":{"date-parts":[[2026,5,12]]}},"alternative-id":["10.1515\/almed-2025-0098"],"URL":"https:\/\/doi.org\/10.1515\/almed-2025-0098","relation":{},"ISSN":["2628-491X"],"issn-type":[{"value":"2628-491X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]}}}